Veteran Owned
Over 30 Years of Experience
Opening Hours
Mon-Fri: 8AM - 5PM

Biogen CEO to step down as company pulls back from Alzheimer’s drug

Michel Vounatsos, Biogen’s CEO since 2017, will be replaced as the company “substantially” eliminates the commercial workforce around Aduhelm, which has generated paltry sales in the face of resistance from insurers and doctors.